Post-Traumatic Knee Osteoarthritis Following Anterior Cruciate Ligament Reconstruction
Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Dec 28, 2023
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of knee joint mechanics in people who have had surgery to repair a torn anterior cruciate ligament (ACL). The goal is to understand how these mechanics change in the first two years after surgery and how they relate to the health of the knee cartilage. This is important because many people develop arthritis in their knees after ACL injuries, and understanding these changes can help improve treatment and recovery.
To participate in the study, you need to be between 18 and 35 years old and either be a healthy volunteer (with no ACL injuries) or someone who has recently had or will have ACL reconstruction surgery using their own hamstring tissue. Healthy volunteers should be active and have a body mass index (BMI) between 18 and 30. The study is currently looking for participants, and those who join can expect to contribute to valuable research that could benefit future patients with similar knee injuries. It’s also important to know that certain pre-existing conditions or significant knee injuries may prevent someone from participating.
Gender
ALL
Eligibility criteria
- Inclusion Criteria (healthy volunteers):
- • Age: 18-35 years
- • No previous anterior cruciate ligament (ACL) injury
- • Body Mass Index (BMI) between 18-30
- • Regular physical activity (active during work or practicing sports regularly)
- • Signed informed consent to participate
- Exclusion Criteria (healthy volunteers):
- • Major injuries to the lower extremities with absence from sports or daily life activities longer than 2 weeks or that required surgery, less than 6 months before participation
- • Pre-existing arthritic disease including inflammatory or infectious arthritis
- Inclusion Criteria (ACL patients):
- • Age: 18-35 years
- • ACL tear which is recently reconstructed or will be reconstructed after enrollment in the current study (the reconstruction will take place within 6 months after injury) with a Hamstring autograft
- • BMI between 18-30
- • Regular physical activity (active during work or practicing sports regularly)
- • Signed informed consent to participate
- Exclusion Criteria (ACL patients):
- • Major injuries to the lower extremities with absence from sports or daily life activities longer than 2 weeks or that required surgery, less than 6 months before participation
- • Pre-existing arthritic disease including inflammatory or infectious arthritis
- • Image based confirmation of local cartilage lesion grade 4 or major cartilage damage (Kellgren \& Lawrence \> 2)
- • Medial collateral ligament damage (\> grade 2)
- • Intra-articular knee fractures
- • Menisectomy with \<80% remnant
About Universitaire Ziekenhuizen Ku Leuven
Universitaire Ziekenhuizen KU Leuven is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with KU Leuven, one of Europe’s premier universities, the institution integrates cutting-edge scientific inquiry with high-quality patient care. It plays a pivotal role in the development and implementation of clinical trials, fostering collaboration between researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective treatments. The hospital's multidisciplinary approach ensures comprehensive patient safety and ethical standards, positioning it as a trusted sponsor in the realm of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leuven, Vlaams Brabant, Belgium
Patients applied
Trial Officials
Sabine Verschueren, PhD
Principal Investigator
KU Leuven
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported